Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 28, 2003

View Archived Issues

ET-743 is associated with changes in the gene expression of sarcoma cells

Preliminary phase I results on EKB-569 for advanced colorectal cancer

Potential use of SB-277011-A in preventing relapse to cocaine abuse

BP-897 ameliorates dyskinesia induced by levodopa in PD

CeNeS strengthens CNS pipeline through acquisition of TheraSci

ELITE trial studies TOBI for early-onset P. aeruginosa in cystic fibrosis

New pivotal Synvisc trial to expand U.S. label

Enrollment completed in phase II Veronate study

Sinovac seeks approval to advance SARS vaccine into clinical testing

WHO collaborates with Acambis on ChimeriVax-JE development

Orphan drug status for Advanced Biotherapy antibodies targeting interferon gamma

Antisoma and EMD Lexigen create immunocytokine fusion protein

BioInvent acquires proteins for development of osteoarthritis therapeutic

Introgen and SWOG to evaluate Advexin plus surgery in phase II trial

Novel 5-HT2C ligands and their use reported by GSK researchers

Enanta presents two series of antibacterial macrolides

New thrombin receptor antagonists prepared and tested at Schering

Schering researchers describe new histamine H3 antagonists and their use

Bayer scientists design new hypoglycemic and hypolipidemic agents

Novel agents for cytomegalovirus infection discovered at Bayer

Potent analgesic activity and favorable safety profile reported for new nAChR agonist

Plenaxis receives FDA approval

Liver histology improvements in phase III study of emtricitabine for hepatitis B

P2X3 receptor antagonist INS-48506 is a potent analgesic in rodent models

Salix submits amendment to NDA for rifaximin

Schering-Plough takes option to license intranasal pleconaril rights

Atypical anxiolytic JNJ-5234801 may be effective at doses not associated with CNS side effects

Improved hemodynamic profile for new iron-containing hematinic agent ABT-870

New drug candidate activates CREB function and ameliorates long-term memory

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...